CELH
Celsius Holdings, Inc.
CELH has the edge over INGR overall, supported by stronger modeled upside and stronger fundamentals.
INGR
Ingredion Incorporated
INGR trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
INGR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
INGR's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
INGR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.6x | $92.72 | — |
| Cheap | 11x | $99.63 | +7.4% |
| Current | 11x | $92.72 | — |
| Fair | 13x | $118 | +27% |
| Expensive | 17x | $150 | +62% |
Historical ranges are pointers, not guarantees.
INGR has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over INGR on the outlook, with more favorable earnings and revenue expectations.
INGR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect INGR's earnings and profitability to decline, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
INGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.63 | +9.5% |
| Q3 2026 | $8.79 | -12% |
| Q2 2026 | $9.17 | -11% |
| Q1 2026 | $10.38 | +9.5% |
| Q4 2025 | $11.16 | +15% |
| Q3 2025 | $10.03 | -2.1% |
| Q2 2025 | $10.25 | +4.8% |
| Q1 2025 | $9.48 | -5% |
| Q4 2024 | $9.71 | +1.1% |
INGR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over INGR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over INGR on profitability, with a higher operating margin.
INGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | -1.3% |
| Q2 2026 | $1.9B | +0.9% |
| Q1 2026 | $1.8B | -1.2% |
| Q4 2025 | $1.8B | -2.4% |
| Q3 2025 | $1.8B | -2.9% |
| Q2 2025 | $1.8B | -2.4% |
| Q1 2025 | $1.8B | -3.7% |
| Q4 2024 | $1.8B | -6.3% |
INGR's revenue fell from its 2023 peak and has held roughly level since: $1.8B last quarter, down 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -2.5 points |
| Q2 2026 | 10% | -4.6 points |
| Q1 2026 | 11% | -3.9 points |
| Q4 2025 | 13% | +3.5 points |
| Q3 2025 | 14% | -0.6 points |
| Q2 2025 | 15% | +2 points |
| Q1 2025 | 15% | +3.9 points |
| Q4 2024 | 9% | -1.5 points |
INGR's operating margin was 11% last quarter, down 2.5 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over INGR on cash flow, with more consistent year-over-year improvement.
INGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $163M | -5.2% |
| Q2 2026 | -$10M | -112% |
| Q1 2026 | -$77M | -$62M |
| Q4 2025 | $270M | -11% |
| Q3 2025 | $172M | -60% |
| Q2 2025 | $84M | -67% |
| Q1 2025 | -$15M | -110% |
| Q4 2024 | $305M | -6.7% |
INGR still generates free cash flow, though less than at its 2024 peak: $346M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
INGR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -200K shares |
| 1 year | -2.6% | -1.7M shares |
| 3 years | -4.9% | -3.3M shares |
| 5 years | -5.8% | -3.9M shares |
| Available history | -5.5% | -3.7M shares |
INGR has the edge over CELH on shareholder dilution, with a more favorable share count trend.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over INGR on leverage, with a lower net debt burden relative to earnings.
INGR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.8x | Very low |
INGR's net debt is less than a year of its operating earnings (EBITDA).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
INGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.4 | Neutral |
| Stochastic | 15.9 | Oversold |
INGR's weekly RSI is 35 (neutral) and its Stochastic is 16 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
INGR PE vs Consumer Defensive Sector
| Metric | INGR | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 19x | 46% below |
| PE % | 8 | 18 | 10 pts below |
INGR has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over INGR on trend strength, trading above more of its moving averages.
INGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $95.3 | 2.7% below |
| 20 week MA | $99.1 | 6.4% below |
| 50 week MA | $105.9 | 12% below |
| 100 week MA | $117.5 | 21% below |
| 200 week MA | $115.4 | 20% below |
INGR is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
INGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.2 | $79.4 | -16% |
| 2021 | $79.4 | $94.8 | +19% |
| 2022 | $94.8 | $98.9 | +4.3% |
| 2023 | $98.9 | $108.5 | +9.8% |
| 2024 | $108.5 | $138.6 | +28% |
| 2025 | $138.6 | $111.4 | -20% |
| 2026 YTD | $111.4 | $92.7 | -17% |
INGR has the edge over CELH on returns for 2026, with the stronger performance.